eli lilly retatrutide ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Today, we shared new data

doi:10.1021/acs.jmedchem.5b00726 Hay DL, et al

Awasthi S

Users frequently mention the supplements impact on digestive comfort, with many reporting reduced bloating within the first few weeks of use

Retatrutide is a triple receptor agonist (GLP-1, GIP, and glucagon) that suppresses appetite, improves insulin sensitivity, and promotes overall weight loss averaging 24.2% over 48 weeks in clinical trials

Netea et al., 2020

Adipose tissue and GLP-1R signalling Intra-articular adipose tissue deposits, known as articular fat pads, are present in the joint, and the main adipose structure within the knee joint is the infrapatellar fat pad (IFP), also called Hoffa's fat pad